Skip to search.
 TSX Down 0.03% TSX Ventures Up 0.42%

Nuvo Research, Inc. (NRI.TO)

-Toronto
6.70 Up 0.10(1.52%) May 26, 3:23PM EDT
Prev Close:6.60
Open:6.64
Bid:6.51
Ask:6.85
1y Target Est:N/A
Beta:-0.393214
Earnings Date:Aug 3 - Aug 8 (Est.)
Day's Range:6.63 - 6.81
52wk Range:3.32 - 7.14
Volume:12,902
Avg Vol (3m):21,476
Market Cap:76.96M
P/E (ttm):N/A
EPS (ttm):-0.75
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in CAD.

Key Statistics

Forward P/E (1 yr):7.36
P/S (ttm):3.05
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :0.79
Quarterly EPS Est (Jun-16) :0.20
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Nuvo Research Inc. operates as a life sciences company. The company operates through two segments, Nuvo Pharma and Crescita. It offers Pennsaid, a topical non-steroidal anti-inflammatory drug that is used to treat the signs and symptoms of osteoar... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback